How can devices better brace stormy weather? Have your say
This article was originally published in Clinica
The US Food and Drug Administration is inviting feedback on the potential effects of extreme weather and natural disasters on the safety and quality of medical devices.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.